Press Releases

Featured Press Releases

BIO Statement on Most Favored Nation

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies:"For too many years, Americans have subsidized the research…

Learn more

BIO Statement on Industry Tariffs

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on the potential for 100% tariffs on branded or patented medicines in the US:“We share the Administration’s…

Learn more

BIO Extends Agreement with Avantor for Five…

Collaboration maximizes BIO members’ access to Avantor’s market-leading portfolio of products, materials, and services to accelerate scientific innovation. WASHINGTON, D.C., September 17, 2025 - The Biotechnology Innovation Organization (BIO)…

Learn more

BIO Applauds Sens. Tillis, Sinema, Peters, and Perdue for Introducing the Fostering Innovation Act

February 13, 2019

The Biotechnology Innovation Organization (BIO) applauds Sens. Thom Tillis (R-NC), Kyrsten Sinema (D-AZ), Gary Peters (D-MI), and David Perdue (R-GA) for introducing the Fostering Innovation Act (S.452) to build on the success of the Jumpstart Our…

New Report Demonstrates High Costs and Low Benefits of Sarbanes-Oxley 404(b) Compliance for Emerging Biotechs

February 11, 2019

Washington, DC (February 11, 2019) – Today, to recognize National Inventors’ Day, the Biotechnology Innovation Organization (BIO) released a new report, “Science or Compliance: Will Section 404(b) Compliance Impede Innovation by Emerging Growth…

BIO Announces Brent Erickson to Step Down as Executive Vice President, Industrial and Environmental Section

February 11, 2019

The Biotechnology Innovation Organization (BIO) announced today that after 19 years leading the Industrial and Environmental Section, Executive Vice President Brent Erickson will step down from the organization in March 2019 to begin new business…

BIO Encouraged by Improved U.S. Ranking in Global Index of Patent System Strength

February 7, 2019

But New Legislative Proposals Endanger Progress

BIO Statement on Hatch-Waxman Integrity Act of 2019

February 6, 2019

BIO applauds the leadership of Senator Thom Tillis (R- NC) and Congressman Bill Flores (R-17 TX) for introducing the “Hatch-Waxman Integrity Act of 2019” to preserve the time-tested approach of the HWA while strengthening the ability of patent…

BIO Statement on State of the Union Address

February 5, 2019

BIO’s President and CEO Jim Greenwood issues statement on President Trump’s State of the Union Address.

BIO Statement on New Proposal for Lowering Out-of-Pocket Costs for Medicines

January 31, 2019

BIO’s President and CEO Jim Greenwood issued a statement after the Trump administration released a proposed rule that would alter safe harbor policies under the federal anti-kickback statute.

BIO Statement Ahead of Chinese Vice Premier Visit to Washington

January 29, 2019

"President Trump has taken unprecedented measures to take on China – our largest trading partner – for its history of trade abuses. Beijing has long imposed unjustified restrictions on U.S. companies seeking to do business in and export to China,…

BIO Statement on China Approvals of Agricultural Biotechnology Products

January 17, 2019

Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement on the announcement that the People’s Republic of China’s National Biosafety Committee approved the final safety certificate for five…

New Platform for Innovation in Food and Agriculture Launches, Invites Broad Conversation

January 16, 2019

WASHINGTON, DC – Jan. 16, 2019 – Today, the Biotechnology Innovation Organization (BIO) and the American Seed Trade Association (ASTA) jointly announce the launch of Innovature, a new platform to spark a thoughtful dialogue around innovation in food…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.